Ayala Pharmaceuticals Inc (ADXS)

[equaloppforall]

Fbg, I fundamentally disagree with that view. Companies are not sold based on what feels ok to retail investors who are tired of their investment. I understand your frustration after 8 long years of holding, but a sale will only be based on the assets that ADXS has.

Picture this: AMGN comes to Lombardo and says, "We want to buy you out for $25/share" to which the former responds "Can you tell me how you arrived that price, so I can inform my board?". Do you really see AMGN simply saying, your SP is $6.50 as of 7/12/17 and we are offering you a 300% premium, NO MORE EXPLANATION".

Think about the glaring flaws in this offer.

1) It is based on the SP to which HFT has brought it down and presupposes that it will never ever rise up again, based on its near future catalysts and clinical progress.

2) It refuses to acknowledge the worth of any of ADXS' products individually, based on clinical results till date and anticipated milestones. I see you talking about the deals with AMGN and Sellas but nothing about Merck and BMS, even if not monetized yet.

ADXS will not be sold tomorrow morning based on the utterly manipulated, HFT-driven SP we are at now. If it gets sold, it will be based on a reasonable premium over a more fairly priced stock, which accounted for all of ADXS' products. This will happen in the next several months, give or take a few.

I urge you not to push this low ball buyout, not because it will happen as a consequence but doing so constantly will only create an image of "heavily manipulated stock with not too much upside" in the minds of vulnerable retail who might otherwise buy this. In other words, you are hurting yourself, even if unintentionally.

Lastly, why even insist on putting a number on the buyout? We'll see what the offers are for when they come.